Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

NCT05049538 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Clear Cell Adenocarcinoma
Endometrial Dedifferentiated Carcinoma
Endometrial Mucinous Adenocarcinoma
Endometrial Serous Adenocarcinoma
Malignant Uterine Neoplasm
Uterine Corpus Carcinosarcoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Liquid Biopsy
OTHER: Pap Smear

Sponsor

M.D. Anderson Cancer Center